IRIS Accounts Production v23.1.0.753 12634726 Board of Directors Board of Directors 1.1.22 31.12.22 31.12.22 22/8/2023 0 0 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure126347262021-12-31126347262022-12-31126347262022-01-012022-12-31126347262020-12-31126347262021-01-012021-12-31126347262021-12-3112634726ns16:EnglandWales2022-01-012022-12-3112634726ns15:PoundSterling2022-01-012022-12-3112634726ns11:Director12022-01-012022-12-3112634726ns11:Director22022-01-012022-12-3112634726ns11:PrivateLimitedCompanyLtd2022-01-012022-12-3112634726ns11:SmallEntities2022-01-012022-12-3112634726ns11:Audited2022-01-012022-12-3112634726ns11:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3112634726ns11:SmallCompaniesRegimeForAccounts2022-01-012022-12-3112634726ns11:FullAccounts2022-01-012022-12-3112634726ns11:Director32022-01-012022-12-3112634726ns11:RegisteredOffice2022-01-012022-12-3112634726ns6:CurrentFinancialInstruments2022-12-3112634726ns6:CurrentFinancialInstruments2021-12-3112634726ns6:ShareCapital2022-12-3112634726ns6:ShareCapital2021-12-3112634726ns6:RetainedEarningsAccumulatedLosses2022-12-3112634726ns6:RetainedEarningsAccumulatedLosses2021-12-3112634726ns6:WithinOneYearns6:CurrentFinancialInstruments2022-12-3112634726ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-31
REGISTERED NUMBER: 12634726 (England and Wales)


















K & W BLOODSTOCK LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022






K & W BLOODSTOCK LIMITED (REGISTERED NUMBER: 12634726)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3 to 4


K & W BLOODSTOCK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2022







DIRECTORS: H M Leach
G O Leach
A H Lewis



REGISTERED OFFICE: Creswell House
Fieldway
Heath
CF14 4UH



REGISTERED NUMBER: 12634726 (England and Wales)



AUDITORS: MHA
Chartered Accountants and Statutory Auditor
Swansea, United Kingdom



AUDITORS OFFICE: 3 New Mill Court
Swansea Enterprise Park
Swansea
SA7 9FG

K & W BLOODSTOCK LIMITED (REGISTERED NUMBER: 12634726)

BALANCE SHEET
31 DECEMBER 2022

2022 2021
Notes £    £   
CURRENT ASSETS
Stocks 383,270 371,318
Debtors 4 4,165 222,255
Cash at bank 635,698 31,172
1,023,133 624,745
CREDITORS
Amounts falling due within one year 5 335,018 335,018
NET CURRENT ASSETS 688,115 289,727
TOTAL ASSETS LESS CURRENT
LIABILITIES

688,115

289,727

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 688,113 289,725
688,115 289,727

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 August 2023 and were signed on its behalf by:




H M Leach - Director



G O Leach - Director


K & W BLOODSTOCK LIMITED (REGISTERED NUMBER: 12634726)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022


1. STATUTORY INFORMATION

K & W Bloodstock Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


Monetary amounts in these financial statements are rounded to nearest £.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future.

The directors have reviewed the balance sheet and the company's likely future cash flows.

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources in place to continue in operational existence for the foreseeable future.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Stocks
Stocks are valued at the lower of cost and net realisable value, being estimated selling price less costs to sell.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


K & W BLOODSTOCK LIMITED (REGISTERED NUMBER: 12634726)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2022


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2021 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Other debtors - 220,646
VAT 4,165 1,609
4,165 222,255

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Amounts owed to group undertakings 335,018 335,018

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Brian Garland BA ACA (Senior Statutory Auditor)
for and on behalf of MHA

7. ULTIMATE CONTROLLING PARTY

The company is a wholly owned subsidiary of Knox & Wells Holdings Limited, a company registered in England and Wales.

The smallest and largest group in which the company has been consolidated is Knox & Wells Holdings Limited.

Copies of the consolidated financial statements of Knox & Wells Holdings Limited can be obtained from the registered office at Creswell House, Fieldway, Heath, Cardiff.

The directors do not consider there to be a ultimate controlling party.